TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 2 | 1 | 2 | 3 | 1 | 16 | 33 | 19 | 42 | 19 |
| P | %wins | 100 | 100 | 50 | 100 | 50 | 100 | 83 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/29/07 12:55 | 5/24/07 | EMN | Eastman Chemical Co | DE | Chem | PlMat | Plastic Materials, Synth Resi | McLain Thomas H | TN | D | P | 65 | 65.73 | 33 | 1 | 144 | 2 | D | 18 | 26 | 12 | 10 | 0 | 0 | 0 | 0 | 1 | 0 | -1 | 4 | -7 | 15 | |
8/10/04 11:10 | 8/6/04 | NABI | Nabi Biopharmaceuticals | DE | Health | BioPrd | Biological Products, (No Diag | McLain Thomas H | FL | DO | CB,CEO,P | P | 1 | 10.45 | 7 | 0 | 0 | 47 | I | 55 | 59 | -41 | -48 | -37 | -32 | -20 | -16 | 5 | 2 | 33 | 61 | 45 | 68 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |